-
Survivor Profile
Putting Her Armor OnAn acute myeloid leukemia survivor and former TV news reporter finds a new reason to help others improve their health.
by Jennifer Walker
-
Forward Look
Advances in Treating Non–Small Cell Lung CancerExpanded approvals in 2016 increase options.
by Jennifer L.W. Fink
-
But I Already Have Cancer
For a patient with advanced cancer, how important is screening for other types of cancer?
by Ide Mills
-
Forward Look
Longer Treatment May Benefit Some Breast Cancer PatientsTen years of hormone therapy studied.
by Sue Rochman
-
Forward Look
No Link Found Between IVF and Breast Cancer RiskStudy findings will reassure many families.
by Cameron Walker
-
Screening Gets Personal
Conflicting and changing cancer screening guidelines have led to uncertainty and controversy. Can screening recommendations tailored for groups or individuals enhance benefits and reduce harms?
by Kate Yandell
-
Forward Look
Little Consensus on Ovarian Cancer MonitoringTests and scans may be overused.
by Kate Yandell
-
Survivor Profile
Going Full BoreSusan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense.
by Sue Rochman
-
Integrative Strategies for Facing Cancer
Brain tumor survivor uses her experiences to help others.
by Jeannine Walston
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles